Skip to content

A Randomized Controlled Trial of Ultra-High-Definition Non-Magnifying Endoscopy versus Magnifying Endoscopy for the Screening of Early Gastric Cancer

A Randomized Controlled Trial of Ultra-High-Definition Non-Magnifying Endoscopy versus Magnifying Endoscopy for the Screening of Early Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128951
Enrollment
Unknown
Registered
2026-07-28
Start date
2026-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Gastric Cancer

Interventions

Magnifying Endoscopy Group:Participants undergo magnifying endoscopy, with lesion assessment and targeted biopsy decisions guided by the MESDA-G algorithm.
4K Ultra-High-Definition Non-Magnifying Endoscopy Group:Participants undergo 4K ultra-high-definition non-magnifying endoscopy, with lesion screening and targeted biopsy decisions guided by the SPEG-H

Sponsors

The Seventh Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 40–75 years who are scheduled to undergo upper gastrointestinal endoscopy for either clinical indications or screening purposes; 2.Willingness to participate in the study, with written informed consent obtained prior to the examination.

Exclusion criteria

Exclusion criteria: 1.Individuals undergoing any therapeutic gastroscopic procedures, including emergency endoscopy; 2.Known, untreated gastric cancer or precancerous lesions; 3.Other malignant tumors of the upper gastrointestinal tract; 4.Individuals who have undergone partial or total gastrectomy; 5.Individuals with severe underlying diseases, such as cardiac or pulmonary insufficiency, cerebrovascular disease, or other conditions precluding careful endoscopic observation; 6.Individuals with gastric retention, esophageal strictures, or other conditions that prevent thorough observation of the stomach; 7.Individuals who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
Positive predictive value of biopsy for early gastric cancer screening using ultra-high definition non-magnifying endoscopy versus magnifying endoscopy;

Secondary

MeasureTime frame
Detection rate of ultra-high definition non-magnifying endoscopy versus magnifying endoscopy for early gastric cancer patients;Procedure time of ultra-high definition non-magnifying endoscopy versus magnifying endoscopy for screening early gastric cancer; Detection rate of ultra-high definition non-magnifying endoscopy versus magnifying endoscopy for early esophageal cancer;Positive predictive value of targeted biopsy for early esophageal cancer using ultra-high definition non-magnifying endoscopy versus magnifying endoscopy;

Countries

China

Contacts

Public ContactPeng Jin

The Seventh Medical Center of Chinese PLA General Hospital

jinpeng@301hospital.com.cn+86 134 6667 1195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026